168 related articles for article (PubMed ID: 9126041)
1. Risk of malignancy and death in neurofibromatosis.
Poyhonen M; Niemela S; Herva R
Arch Pathol Lab Med; 1997 Feb; 121(2):139-43. PubMed ID: 9126041
[TBL] [Abstract][Full Text] [Related]
2. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
[TBL] [Abstract][Full Text] [Related]
3. Malignant peripheral nerve sheath tumors developing multifocally in the central nervous system in a patient with neurofibromatosis type 2.
Higami Y; Shimokawa I; Kishikawa M; Okimoto T; Ohtani H; Tomita M; Tsujino A; Ikeda T
Clin Neuropathol; 1998; 17(2):115-20. PubMed ID: 9561334
[TBL] [Abstract][Full Text] [Related]
4. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D
Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
[TBL] [Abstract][Full Text] [Related]
5. Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.
Friedrich RE; Kluwe L; Fünsterer C; Mautner VF
Anticancer Res; 2005; 25(3A):1699-702. PubMed ID: 16033085
[TBL] [Abstract][Full Text] [Related]
6. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
7. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1.
Ferrari A; Bisogno G; Macaluso A; Casanova M; D'Angelo P; Pierani P; Zanetti I; Alaggio R; Cecchetto G; Carli M
Cancer; 2007 Apr; 109(7):1406-12. PubMed ID: 17330850
[TBL] [Abstract][Full Text] [Related]
8. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
[TBL] [Abstract][Full Text] [Related]
9. Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases.
McCarron KF; Goldblum JR
Mod Pathol; 1998 Jul; 11(7):612-7. PubMed ID: 9688181
[TBL] [Abstract][Full Text] [Related]
10. [Extracerebral neoplastic manifestations in neurofibromatosis 1: integrated diagnostic imaging].
Ferrozzi F; Zuccoli G; Bacchini E; Piazza P; Sigorini M; Virdis R
Radiol Med; 1998 Dec; 96(6):562-9. PubMed ID: 10189917
[TBL] [Abstract][Full Text] [Related]
11. [Intracranial and intramedullary peripheral nerve sheath tumours. Case reports from 20 autopsies].
Aguirre-Quezada DE; Martínez-Anda JJ; Aguilar-Ayala EL; Chávez-Macías L; Olvera-Rabiela JE
Rev Neurol; 2006 Aug 16-31; 43(4):197-200. PubMed ID: 16883507
[TBL] [Abstract][Full Text] [Related]
12. Benign nerve sheath tumors on urinary bladder biopsy.
Wang W; Montgomery E; Epstein JI
Am J Surg Pathol; 2008 Jun; 32(6):907-12. PubMed ID: 18425043
[TBL] [Abstract][Full Text] [Related]
13. The role of surgery in children with neurofibromatosis.
Neville HL; Seymour-Dempsey K; Slopis J; Gill BS; Moore BD; Lally KP; Andrassy RJ
J Pediatr Surg; 2001 Jan; 36(1):25-9. PubMed ID: 11150433
[TBL] [Abstract][Full Text] [Related]
14. A superficial form of malignant peripheral nerve sheath tumour associated with segmental neurofibromatosis.
Li K; Won CH; Moon SE
Acta Derm Venereol; 2005; 85(6):540-1. PubMed ID: 16396811
[No Abstract] [Full Text] [Related]
15. Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors.
Wentworth S; Pinn M; Bourland JD; Deguzman AF; Ekstrand K; Ellis TL; Glazier SS; McMullen KP; Munley M; Stieber VW; Tatter SB; Shaw EG
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):208-13. PubMed ID: 18687535
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis and malignant schwannomas in Tanzania.
Amir H; Moshi E; Kitinya JN
East Afr Med J; 1993 Oct; 70(10):650-3. PubMed ID: 8187663
[TBL] [Abstract][Full Text] [Related]
17. Incidence, types, and management of cancer in patients with neurofibromatosis.
Cohen BH; Rothner AD
Oncology (Williston Park); 1989 Sep; 3(9):23-30; discussion 34, 37-8. PubMed ID: 2518324
[TBL] [Abstract][Full Text] [Related]
18. Malignant peripheral nerve sheath tumor with neurofibromatosis type 1: a 2-case report and review of the literature.
Asavamongkolkul A; Jiranantakan T; Waikakul S; Phompitaksa K; Muangsomboon S
J Med Assoc Thai; 2001 Feb; 84(2):285-93. PubMed ID: 11336091
[TBL] [Abstract][Full Text] [Related]
19. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
Friedrich RE; Hartmann M; Mautner VF
Anticancer Res; 2007; 27(4A):1957-60. PubMed ID: 17649804
[TBL] [Abstract][Full Text] [Related]
20. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
Sharif S; Ferner R; Birch JM; Gillespie JE; Gattamaneni HR; Baser ME; Evans DG
J Clin Oncol; 2006 Jun; 24(16):2570-5. PubMed ID: 16735710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
